luan chao ai de mian yi zhi liao
Author(s): DI Wen, WU Xia
Pages: 165-168
Year: 2010 Issue: 3
Journal: Chinese Journal of Practical Gynecology and Obstetrics
Keyword: ovarian cancer; immunotherapy; cancer immunoediting; chemotherapy;
Abstract: 卵巢癌是最致命的妇科恶性肿瘤。肿瘤免疫治疗有望成为改善患者预后的重要策略。该文对肿瘤免疫机制、卵巢癌免疫治疗的现状和发展、化疗与免疫治疗的协同作用进行了阐述。
Pages: 165-168
Year: 2010 Issue: 3
Journal: Chinese Journal of Practical Gynecology and Obstetrics
Keyword: ovarian cancer; immunotherapy; cancer immunoediting; chemotherapy;
Abstract: 卵巢癌是最致命的妇科恶性肿瘤。肿瘤免疫治疗有望成为改善患者预后的重要策略。该文对肿瘤免疫机制、卵巢癌免疫治疗的现状和发展、化疗与免疫治疗的协同作用进行了阐述。
Citations
- 吴霞,狄文. 化疗对肿瘤免疫治疗的增益作用 [J]. 中国肿瘤生物治疗杂志 . 2007(01)
- 李守柔. 辅助性免疫治疗提高妇科恶性肿瘤常规综合治疗效果的展望 [J]. 中国实用妇科与产科杂志 . 2006(05)
- Wu X,Feng QM,Wang Y,et al. The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and car-boplatin chemotherapy . Cancer Immunology Immunotherapy . 2009
- Rosenberg SA,Yang JC,Restifo NP. Cancer immunotherapy: moving beyond current vaccines . Nature Medicine . 2004
- Dunn G P,Bruce A T,Ikeda H,et al. Cancer immunoediting: from immunosurveillance to tumor escape . Nature Immunology . 2002
- Zhang L,Conejo-Garcia JR,Katsaros D,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer . New England Journal of Medicine, The . 2003
- Cureil TJ,Coukos G,Zou L,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival . Nature Medicine . 2004
- Reinartz S,Kohler S,Schlebusch H,et al. Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II) . Clinical Cancer Research . 2004
- Schlienger K,Chu CS,W oo EY,et al. TRANCE-andCD40 ligand-m atured dendritic cells revealMHC c lass I-restricted T cells spec ific for autologous tumor in late-stage ovarian cancer patients . C lin CancerRes . 2003
- Disis ML,Schiffman K,Guthrie K,et al. Effect of dose on immune response in patients vaccinated with an HER-2/neu intracellular domain protein-based vaccine . Journal of Clinical Oncology . 2004
- Sabbatini P,Odunsi K. Immunologic approaches to ovarian cancer treatment . Journal of Clinical Oncology . 2007
- Kershaw MH,Westwood JA,Parker LL,et al. A phase I study onadoptive immunotherapy using gene-modified T cells for ovariancancer . Clinical Cancer Research . 2006
Related Articles